Table 3.

Antibacterial and antifungal activity of samples zone of inhibition in mm) and in percentage.

Compound details	Zone of inhibition in mm and percentage @ 25 μg/mL
	S.A mm	S.A %	S.P mm	S.P %	E.C mm	E.C %	P.A mm	P. A %	C.A mm	C. A %	A.C mm	A.C %
	Gram-positive bacteria				Gram-negative bacteria				Fungal strains
	2-phenyl benzoxazole scaffold
Sample -1	15	54%	17	69%	10	40%	15	55%	21	68%	21	68%
Sample -2	20	72%	15	61%	12	50%	16	62%	23	73%	22	70%
Sample -3	16	58%	11	47%	15	63%	17	67%	24	78%	23	73%
Sample -4	20	72%	18	73%	17	61%	18	71%	20	64%	21	68%
Sample -5	19	63%	18	68%	15	61%	13	56%	21	68%	20	64%
Sample -6	14	51%	15	60%	13	55%	16	62%	22	70%	18	55%
Sample -7	19	66%	16	65%	18	63%	18	71%	23	73%	19	59%
Sample -8	16	58%	18	73%	18	63%	13	51%	21	68%	17	52%
Sample -9	17	61%	13	51%	17	61%	16	62%	22	70%	18	55%
Sample -10	13	54%	11	50%	7	35%	12	50%	21	68%	21	68%
Sample -11	12	50%	21	82%	17	61%	16	62%	20	64%	22	70%
Sample -12	19	68%	19	76%	19	66%	13	51%	19	61%	20	64%
Sample -13	14	49%	14	60%	15	70%	18	71%	21	68%	19	59%
Sample -14	18	63%	16	65%	18	72%	13	51%	20	64%	21	68%
	2-N-phenyl benzoxazole scaffold
Sample -15	17	61%	18	73%	16	60%	16	62%	21	68%	23	73%
Sample -16	15	53%	17	67%	19	76%	14	50%	22	70%	22	70%
Sample -17	19	66%	16	65%	16	65%	17	67%	20	64%	21	68%
Sample -18	21	81%	19	82%	20	85%	22	76%	19	61%	20	64%
Sample -19	20	72%	12	47%	19	77%	14	60%	21	68%	19	59%
Sample -20	18	63%	15	61%	17	69%	15	59%	23	73%	17	52%
Sample -21	23	80%	22	85%	22	90%	20	72%	22	70%	19	59%
Sample -22	21	78%	19	76%	20	80%	17	67%	21	68%	21	68%
Sample -23	16	58%	20	79%	16	66%	12	47%	20	64%	20	64%
Sample -24	14	50%	17	69%	17	69%	18	71%	19	61%	21	68%
Sample -25	19	66%	16	65%	18	73%	13	51%	22	70%	18	55%
Sample -26	21	78%	17	69%	19	78%	12	47%	21	68%	22	70%
	Positive controls
Cefixime	22		19		18		20
	29		26		25		28
	33		35		36		37
Griseofulvin									34		35
									47		43
									52		55

CA: Candida albicans; AC: Aspergillus Clavatus. SA: Staphylococcus aureus; SP: Streptococcus pyrogenes; EA: Escherichia coli; PA: Pseudomonas aeruinosa.